Exagen (XGN) Change in Accured Expenses (2018 - 2026)

Exagen (XGN) has reported Change in Accured Expenses for 9 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$1.6 million, down 9.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $112000.0 (up 193.33% YoY), and the FY2025 annual result was $251000.0, up 288.72% from the prior year.
• Change in Accured Expenses was -$1.6 million for Q1 2026 at Exagen, down from $681000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $1.2 million in Q3 2023 and troughed at -$1.6 million in Q1 2026.
• Average Change in Accured Expenses over 5 years is -$20235.3, with a median of $89000.0 recorded in 2022.
• Year-over-year, Change in Accured Expenses sank 645.45% in 2022 and soared 903.37% in 2023.
• Over 5 years, Change in Accured Expenses stood at -$1.3 million in 2022, then surged by 138.8% to $497000.0 in 2023, then surged by 102.62% to $1.0 million in 2024, then plunged by 32.37% to $681000.0 in 2025, then tumbled by 328.63% to -$1.6 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$1.6 million in Q1 2026, $681000.0 in Q4 2025, and $1.2 million in Q3 2025.